|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.23 USD | -8.73% |
|
-20.72% | -44.71% |
InMed Pharmaceuticals Inc. reported earnings results for the full year ended June 30, 2023. For the full year, the company reported sales was USD 4.14 million compared to USD 1.09 million a year ago. Net loss was USD 7.95 million compared to USD 18.6 million a year ago.
Basic loss per share from continuing operations was USD 3.25 compared to USD 33.17 a year ago. Diluted loss per share from continuing operations was USD 3.25 compared to USD 33.17 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -44.71% | 1.39M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
INMED PHARMACEUTICALS INC. 
